Aldeyra Therapeutics
ALDX
#10254
Rank
โ‚ฌ45.44 M
Marketcap
0,75ย โ‚ฌ
Share price
14.37%
Change (1 day)
-82.12%
Change (1 year)

EPS for Aldeyra Therapeutics (ALDX)

EPS in 2026 (TTM): -0,38ย โ‚ฌ

According to Aldeyra Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,40ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,51ย โ‚ฌ an increase over its 2024 EPS that were of -0,86ย โ‚ฌ.

EPS history for Aldeyra Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,38ย โ‚ฌ-26.01%
2025-0,51ย โ‚ฌ-40.43%
2024-0,86ย โ‚ฌ46.88%
2023-0,58ย โ‚ฌ-39.62%
2022-0,97ย โ‚ฌ-0.93%
2021-0,97ย โ‚ฌ-3.6%
2020-1,01ย โ‚ฌ-50.45%
2019-2,04ย โ‚ฌ25.14%
2018-1,63ย โ‚ฌ27.86%
2017-1,27ย โ‚ฌ-15.15%
2016-1,50ย โ‚ฌ17.86%
2015-1,27ย โ‚ฌ-44.22%
2014-2,29ย โ‚ฌ-174.03%
20133,09ย โ‚ฌ24.19%
20122,49ย โ‚ฌ-134.46%
2011-7,21ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
42,77ย โ‚ฌ-10,777.27%๐Ÿ‡บ๐Ÿ‡ธ USA